Editorial
doi: 10.1016/j.jaip.2015.12.002.
Monitoring Allergic Patients on Omalizumab with Free and Total Serum IgE Measurements
Affiliations
- PMID: 26968963
- DOI: 10.1016/j.jaip.2015.12.002
Item in Clipboard
Editorial
Monitoring Allergic Patients on Omalizumab with Free and Total Serum IgE Measurements
J Allergy Clin Immunol Pract.
2016 Mar-Apr.
No abstract available
Comment on
-
Measuring total IgE is useful in detecting exacerbations in patients with allergic bronchopulmonary aspergillosis receiving omalizumab.J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):361-3. doi: 10.1016/j.jaip.2015.10.020. Epub 2015 Dec 24. J Allergy Clin Immunol Pract. 2016. PMID: 26725156 No abstract available.
-
Following total IgE concentration in patients with allergic bronchopulmonary aspergillosis on omalizumab.J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):364-5. doi: 10.1016/j.jaip.2015.11.014. Epub 2015 Dec 24. J Allergy Clin Immunol Pract. 2016. PMID: 26725160 No abstract available.
Similar articles
-
Severe persistent asthma responsive to off-label use of omalizumab despite high and low levels of total serum IgE.J Bras Pneumol. 2011 Jul-Aug;37(4):567-70. doi: 10.1590/s1806-37132011000400021. J Bras Pneumol. 2011. PMID: 21881749 English, Portuguese. No abstract available.
-
Monitoring free serum IgE in severe asthma patients treated with omalizumab.Respir Med. 2012 Nov;106(11):1494-500. doi: 10.1016/j.rmed.2012.07.010. Epub 2012 Aug 11. Respir Med. 2012. PMID: 22884459 Clinical Trial.
-
Effectiveness of omalizumab in a patient with severe asthma, low serum IgE level, and lack of sensitized allergens induced by oral steroid therapy: the usefulness of impulse oscillation for assessment of omalizumab therapy.J Asthma. 2012 Oct;49(8):839-42. doi: 10.3109/02770903.2012.715704. Epub 2012 Aug 24. J Asthma. 2012. PMID: 22920591
-
Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments.Curr Drug Targets. 2015;16(2):171-8. doi: 10.2174/1389450116666141219122157. Curr Drug Targets. 2015. PMID: 25523898 Review.
-
Omalizumab in asthma: an update on recent developments.J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):525-36.e1. doi: 10.1016/j.jaip.2014.03.010. Epub 2014 Jun 11. J Allergy Clin Immunol Pract. 2014. PMID: 25213045 Review.
Cited by
-
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI).Clin Transl Allergy. 2020 Jul 17;10:32. doi: 10.1186/s13601-020-00335-w. eCollection 2020. Clin Transl Allergy. 2020. PMID: 32695309 Free PMC article. Review.
-
Endotyping Chronic Respiratory Diseases: T2 Inflammation in the United Airways Model.Life (Basel). 2024 Jul 19;14(7):899. doi: 10.3390/life14070899. Life (Basel). 2024. PMID: 39063652 Free PMC article. Review.
-
Anti-IgE for the Treatment of Chronic Urticaria.Immunotargets Ther. 2021 Feb 17;10:27-45. doi: 10.2147/ITT.S261416. eCollection 2021. Immunotargets Ther. 2021. PMID: 33628747 Free PMC article. Review.
-
Clinical implications of asthma endotypes and phenotypes.Allergy Asthma Proc. 2022 Sep 1;43(5):375-382. doi: 10.2500/aap.2022.43.220047. Allergy Asthma Proc. 2022. PMID: 36065106 Free PMC article.
-
Allergic Bronchopulmonary Aspergillosis.J Fungi (Basel). 2016 Jun 6;2(2):17. doi: 10.3390/jof2020017. J Fungi (Basel). 2016. PMID: 29376934 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
